A scoping review of neuromodulation techniques for controlling blood pressure: what are the ups and downs to this approach?
Abstract Background and Objectives While there has been rapid progress in research aimed at developing device-based neuromodulation therapies for blood pressure (BP) disorders, there is a paucity of FDA-approved therapies. Currently, the only approved devices for treating resistant hypertension use...
Saved in:
| Main Authors: | Peter L. Greechan, Ryan G. L. Koh, Paul B. Yoo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Bioelectronic Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42234-025-00181-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of office and ambulatory blood pressure in the practice of a primary care physician. Guidelines
by: V. M. Gorbunov, et al.
Published: (2023-09-01) -
EVALUATION OF PROHYPERTENSIVE EFFECT OF MELOXICAM ON THE BLOOD PRESSURE INDICATORS
by: R. V. Nikiforov, et al.
Published: (2019-02-01) -
Arterial hypotension in patients with essential hypertension II–III: unresolved issues and ambulatory blood pressure monitoring diagnostic criteria
by: V. V. Syvolap, et al.
Published: (2022-05-01) -
Take Two: Second Systolic Blood Pressure Provides Prognostic Information in Trauma
by: Esther J. Kim, et al.
Published: (2025-01-01) -
Symptomatic hypotensive episodes in patients with hypertension. Relationship with blood pressure self-monitoring parameters
by: S. A. Ermasova, et al.
Published: (2021-07-01)